Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients

Journal of Communicable Diseases

Volumn 35, Issue 2, 2003, Pages 82-89

  Dhingra, V K ^a   Rajpal, S ^a   Bhalla, P ^b   Yadav, A ^a   Jain, S K ^a   Hanif, M ^a  

^a New Delhi Tuberculosis Centre   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Delhi; Initial drug resistance; RNTCP; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM COLONY; DRUG SENSITIVITY; HUMAN; INCIDENCE; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SMEAR; SPUTUM CULTURE;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE; ETHAMBUTOL; HUMANS; INDIA; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RIFAMPIN; SPUTUM; STREPTOMYCIN; TUBERCULOSIS, PULMONARY;

EID: 4444345654     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jindal SK. Anti-tuberculosis treatment failure in clinical practice. Ind J Tub 1997; 44: 121.
2. Yew WW. Directly observed therapy, short course: the best way to prevent multidrug resistant tuberculosis. Chemotherapy 1999; 45 (supple 2): 26-33.
3. Gangadhran PRJ. Mycobacteria and drug resistance. Tuberculosis (second edition), KN Rao. Vikas Publishing House Pvt. Ltd., New Delhi, 1972. 142-146.
4. Annie L, Vestal BS. Procedures for the isolation and identification of mycobacteria, Centre for Disease Control, Atlanta 1978; 99-103.
5. Carpenter JL, Covell HD, et al. Drug resistant M tuberculosis in Korean isolates. Am Rev Resp Dis 1983; 126: 1092.
6. Carpenter L, Ognibene, et al. Antituberculosis drug resistance in South Texas. Am Rev Resp Dis 1983; 128: 1055.
7. Centres for Disease Control, Atlanta: Drug resistance among Indochinese refugees with tuberculosis, MMWR 1981; 20(12): 273.
8. Trivedi SS and Desai SO. Primary anti tuberculosis drug resistance and acquired rifampicin resistance in Gujarat in India. Tubercle 1988; 69: 37-42.
9. Chandrasekaran S, Jagota P and Chaudhuri K. Initial drug resistance to anti-tuberculosis drugs in urban and rural tuberculosis programme. Ind J Tub 1992; 39: 171-75.
10. Chandersekaran S, Chauhan MM, Rajalakashmi R, Chaudhuri K and Mahadev B. Initial drug resistance to antituberculosis drugs in patients attending urban district tuberculosis centre. Ind J Tub 1990; 37: 215-216.
11. 11: Indian Council of Medical Research: First drug resistance investigation. Ind J Med Res 1968; 56: 1617-30.
12. Indian Council of Medical Research: Second drug resistance investigation. Ind J Med Res 1969; 57: 823-35.
13. Sidiqi SH, Aziz A, Regglerdo Z and Middlebook G. Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis. J Clin Pathol 1981; 34: 927-9.
14. Pien FD, Anuj KS and Chan H. Primary antituberculosis drug resistance in Hawaii 1977-1981. Am Rev Respir Dis 1982; 120-129.
15. Toman K. Tuberculosis case finding and chemotherapy: Question and Answers. WHO, Geneva, 1979. 1-239.
16. Enarson DA. International Union against Tuberculosis and Lung Disease: Model National Tuberculosis Programmes. Tubercle and Lung Disease 1995; 76: 95.